Jennifer P Wang, MD
Ophthalmology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 24
- 5 carriers
- Office
- 1
Offices
1 location
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
24 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Wang’s office at (650) 969-4600 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
24 of 24 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A76003 · Current
Licensed to practise in California · since 2001 · expires 2026-10-31 · Wright State University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$109,571
Medicare paid this office $109,571 for 377 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient complete exam of visual system | 247 | $28,580 | $114 |
| Return visit (30+ min) | 104 | $16,265 | $113 |
| Removal of cataract with insertion of prosthetic lens | 18 | $15,743 | $525 |
| New patient visit (45+ min) | 71 | $10,010 | $141 |
| Short return visit (20+ min) | 68 | $8,377 | $82 |
See all 12 services
| Established patient complete exam of visual system | 247 | $28,580 | $114 |
| Return visit (30+ min) | 104 | $16,265 | $113 |
| Removal of cataract with insertion of prosthetic lens | 18 | $15,743 | $525 |
| New patient visit (45+ min) | 71 | $10,010 | $141 |
| Short return visit (20+ min) | 68 | $8,377 | $82 |
| Exam of visual field with extended testing | 53 | $3,151 | $57 |
| Short return visit | 38 | $2,226 | $52 |
| Imaging of optic nerve | 36 | $1,220 | $30 |
| Measurement of corneal curvature and depth of eye | 20 | $1,173 | $37 |
| Ct scan of cornea | 20 | $819 | $26 |
| Removal of eyelashes using forceps | 12 | $334 | $19 |
| Photography of content of eyes | 12 | $321 | $25 |
Procedures Medicare counted
| Cataract surgery | 34 | More than 56% of doctors who do this |
| Melanoma (skin cancer) excision | 1-10 | None |
Who their Medicare patients are
377 Original Medicare patients in 2024. Average age 77 · Women 57% · Health risk score 0.85. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 65% · Coronary heart disease 21% · Diabetes 20% · Cancer 18% · Atrial fibrillation 17% · Heart failure 12% · Chronic kidney disease 12% · Depression 10% · COPD 9% · Stroke 7% · Dementia 4%.
The office billed $564,115, Medicare allowed $147,340 and paid $109,571; for 911 services of 35 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 377 | 911 | 77 | 0.85 | $564,115 | $109,571 |
| 2023 | 381 | 970 | 77 | 0.84 | $559,437 | $107,379 |
| 2022 | 362 | 863 | 77 | 0.85 | $422,756 | $97,022 |
| 2021 | 344 | 770 | 77 | 0.81 | $363,561 | $83,930 |
| 2020 | 287 | 765 | 76 | 0.86 | $379,368 | $79,566 |
| 2019 | 338 | 1,021 | 76 | 0.93 | $404,431 | $92,347 |
| 2018 | 285 | 722 | 76 | 0.90 | $274,328 | $70,271 |
| 2017 | 285 | 752 | 77 | 0.89 | $265,808 | $69,140 |
| 2016 | 320 | 681 | 76 | 0.94 | $304,704 | $80,448 |
| 2015 | 326 | 755 | 76 | 0.92 | $293,055 | $82,857 |
| 2014 | 329 | 879 | 76 | 0.91 | $350,460 | $94,666 |
| 2013 | 345 | 887 | 76 | 0.85 | $328,910 | $97,719 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Established patient complete exam of visual system | 243 | $26,513 | $108 |
| Return visit (30+ min) | 99 | $15,922 | $114 |
| Removal of cataract with insertion of prosthetic lens | 19 | $14,654 | $523 |
| New patient visit (45+ min) | 75 | $10,252 | $137 |
| Short return visit (20+ min) | 75 | $10,247 | $79 |
| Exam of visual field with extended testing | 66 | $4,451 | $63 |
| Imaging of optic nerve | 46 | $1,723 | $33 |
| Short return visit | 23 | $1,386 | $53 |
| Measurement of corneal curvature and depth of eye | 20 | $1,277 | $41 |
| New patient complete exam of visual system | 13 | $1,089 | $84 |
| Ct scan of cornea | 20 | $879 | $28 |
| Imaging of retina | 14 | $450 | $32 |
| Photography of the retina | 13 | $449 | $35 |
| Photography of content of eyes | 13 | $321 | $25 |
2022: 12 services
| Established patient complete exam of visual system | 214 | $23,148 | $108 |
| Return visit (30+ min) | 94 | $13,321 | $113 |
| Removal of cataract with insertion of prosthetic lens | 16 | $12,910 | $516 |
| New patient visit (45+ min) | 76 | $10,066 | $132 |
| Short return visit (20+ min) | 74 | $9,965 | $81 |
| Exam of visual field with extended testing | 50 | $3,305 | $59 |
| New patient complete exam of visual system | 16 | $2,159 | $135 |
| Imaging of optic nerve | 41 | $1,389 | $32 |
| Measurement of corneal curvature and depth of eye | 17 | $947 | $45 |
| Short return visit | 17 | $930 | $55 |
| Photography of the retina | 24 | $775 | $32 |
| Ct scan of cornea | 18 | $651 | $30 |
2021: 10 services
| Established patient complete exam of visual system | 217 | $23,329 | $107 |
| Return visit (30+ min) | 69 | $9,717 | $114 |
| Short return visit (20+ min) | 69 | $7,944 | $75 |
| New patient visit (45+ min) | 50 | $6,488 | $130 |
| New patient complete exam of visual system | 33 | $4,365 | $132 |
| Exam of visual field with extended testing | 54 | $3,650 | $62 |
| Imaging of optic nerve | 44 | $1,455 | $32 |
| Photography of the retina | 33 | $1,257 | $37 |
| Removal of eyelashes using forceps | 11 | $454 | $22 |
| Photography of content of eyes | 14 | $341 | $24 |
2020: 14 services
| Established patient complete exam of visual system | 197 | $20,038 | $101 |
| Removal of cataract with insertion of prosthetic lens | 19 | $14,523 | $519 |
| Short return visit (20+ min) | 75 | $7,794 | $60 |
| Return visit (30+ min) | 66 | $7,783 | $88 |
| New patient visit (45+ min) | 30 | $3,821 | $127 |
| Exam of visual field with extended testing | 45 | $2,780 | $57 |
| New patient complete exam of visual system | 21 | $2,421 | $115 |
| Measurement of corneal curvature and depth of eye | 22 | $1,232 | $56 |
| Photography of the retina | 26 | $1,180 | $41 |
| Imaging of optic nerve | 36 | $1,157 | $30 |
| Ct scan of cornea | 22 | $651 | $30 |
| Measurement of corneal curvature and depth of eye | 11 | $324 | $29 |
| Extended exam of the back part of the eye with retinal drawing | 13 | $210 | $16 |
| Ct scan of cornea | 11 | $205 | $19 |
2019: 11 services
| Established patient complete exam of visual system | 223 | $23,517 | $105 |
| Removal of cataract with insertion of prosthetic lens | 15 | $14,718 | $613 |
| Short return visit (20+ min) | 86 | $10,192 | $65 |
| New patient visit (45+ min) | 56 | $7,592 | $136 |
| Return visit (30+ min) | 63 | $7,303 | $96 |
| Exam of visual field with extended testing | 58 | $3,753 | $59 |
| New patient complete exam of visual system | 23 | $2,554 | $111 |
| Photography of the retina | 36 | $1,776 | $49 |
| Imaging of optic nerve | 48 | $1,656 | $32 |
| Measurement of corneal curvature and depth of eye | 17 | $1,310 | $55 |
| Ct scan of cornea | 17 | $679 | $28 |
2018: 10 services
| Established patient complete exam of visual system | 201 | $20,592 | $102 |
| Short return visit (20+ min) | 75 | $7,738 | $60 |
| Return visit (30+ min) | 60 | $5,963 | $84 |
| New patient visit (45+ min) | 38 | $4,785 | $126 |
| Exam of visual field with extended testing | 53 | $3,193 | $58 |
| Photography of the retina | 34 | $1,858 | $53 |
| Imaging of optic nerve | 55 | $1,744 | $31 |
| New patient complete exam of visual system | 16 | $1,561 | $98 |
| Measurement of corneal curvature and depth of eye | 11 | $826 | $55 |
| Ct scan of cornea | 11 | $431 | $29 |
2017: 9 services
| Established patient complete exam of visual system | 198 | $19,915 | $100 |
| Removal of cataract with insertion of prosthetic lens | 12 | $11,060 | $582 |
| Short return visit (20+ min) | 85 | $9,508 | $58 |
| Return visit (30+ min) | 47 | $4,805 | $89 |
| Photography of the retina | 52 | $3,183 | $55 |
| Exam of visual field with extended testing | 58 | $3,085 | $52 |
| New patient complete exam of visual system | 23 | $2,928 | $127 |
| New patient visit (45+ min) | 19 | $2,541 | $134 |
| Imaging of optic nerve | 57 | $1,475 | $26 |
2016: 9 services
| Established patient complete exam of visual system | 221 | $23,068 | $103 |
| Removal of cataract with insertion of prosthetic lens | 15 | $14,002 | $583 |
| Short return visit (20+ min) | 79 | $8,448 | $60 |
| Return visit (30+ min) | 43 | $4,621 | $92 |
| New patient visit (45+ min) | 25 | $3,650 | $146 |
| New patient complete exam of visual system | 28 | $3,106 | $111 |
| Exam of visual field with extended testing | 48 | $2,801 | $53 |
| Short return visit | 19 | $816 | $39 |
| Imaging of optic nerve | 18 | $547 | $30 |
2015: 9 services
| Established patient complete exam of visual system | 246 | $26,772 | $105 |
| Removal of cataract with insertion of prosthetic lens | 21 | $17,433 | $601 |
| Short return visit (20+ min) | 97 | $11,072 | $61 |
| Return visit (30+ min) | 43 | $4,213 | $90 |
| Exam of visual field with extended testing | 59 | $3,775 | $62 |
| New patient visit (45+ min) | 20 | $2,776 | $139 |
| New patient complete exam of visual system | 14 | $1,945 | $139 |
| Imaging of optic nerve | 49 | $1,837 | $37 |
| Measurement of corneal curvature and depth of eye | 18 | $1,617 | $60 |
2014: 10 services
| Established patient complete exam of visual system | 226 | $22,909 | $101 |
| Removal of cataract with insertion of prosthetic lens | 24 | $20,930 | $581 |
| Short return visit (20+ min) | 107 | $15,216 | $63 |
| Return visit (30+ min) | 45 | $4,641 | $91 |
| Exam of visual field with extended testing | 71 | $4,399 | $61 |
| New patient visit (45+ min) | 31 | $4,286 | $138 |
| New patient complete exam of visual system | 25 | $2,778 | $111 |
| Measurement of corneal curvature and depth of eye | 23 | $2,290 | $64 |
| Imaging of optic nerve | 59 | $2,217 | $38 |
| Examination of eye by ophthalmoscope with retinal drawing | 15 | $556 | $23 |
2013: 10 services
| Established patient complete exam of visual system | 254 | $24,855 | $97 |
| Removal of cataract with insertion of prosthetic lens | 21 | $18,870 | $609 |
| Short return visit (20+ min) | 104 | $12,546 | $61 |
| Return visit (30+ min) | 49 | $5,425 | $92 |
| Exam of visual field with extended testing | 74 | $4,929 | $63 |
| New patient visit (45+ min) | 23 | $3,076 | $134 |
| New patient complete exam of visual system | 26 | $2,834 | $109 |
| Imaging of optic nerve | 62 | $2,401 | $38 |
| Measurement of corneal curvature and depth of eye | 23 | $2,323 | $75 |
| Examination of eye by ophthalmoscope with retinal drawing | 12 | $497 | $24 |
Drugs they prescribed that Part D paid
$40,102
Pharmacies billed $40,102 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 348) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
211 generic and 137 brand-name prescriptions · $40,102 in drug cost · 22 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 15 | $13,292 | $886 |
| Lumigan | 32 | $13,020 | $407 |
| Tobramycin-Dexamethasone | 77 | $3,358 | $44 |
| Brimonidine Tartrate-Timolol | 14 | $876 | $63 |
| Erythromycin | 43 | $456 | $11 |
See all 7 drugs
| Restasis | 15 | $13,292 | $886 |
| Lumigan | 32 | $13,020 | $407 |
| Tobramycin-Dexamethasone | 77 | $3,358 | $44 |
| Brimonidine Tartrate-Timolol | 14 | $876 | $63 |
| Erythromycin | 43 | $456 | $11 |
| Latanoprost | 59 | $337 | $6 |
| Moxifloxacin | 14 | $319 | $23 |
Year by year
| 2024 | 348 | 113 | 0% (0) | 39% | $40,102 |
| 2023 | 278 | 89 | 0% (0) | 54% | $40,218 |
| 2022 | 271 | 82 | 0% (0) | 54% | $46,062 |
| 2021 | 305 | 87 | 0% (0) | 57% | $50,341 |
| 2020 | 292 | 81 | 0% (0) | 66% | $50,530 |
| 2019 | 326 | 99 | 0% (0) | 57% | $51,996 |
| 2018 | 373 | 96 | 0% (0) | 56% | $54,790 |
| 2017 | 449 | 95 | 0% (0) | 77% | $70,537 |
| 2016 | 409 | 90 | 0% (0) | 75% | $62,929 |
| 2015 | 435 | 97 | 0% (0) | 72% | $58,790 |
| 2014 | 400 | 103 | 0% (0) | 66% | $50,435 |
| 2013 | 362 | 97 | 0% (0) | 60% | $36,743 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Lumigan | 48 | $15,474 | $322 |
| Tobradex St | 15 | $3,830 | $255 |
| Tobramycin-Dexamethasone | 26 | $1,200 | $46 |
| Latanoprost | 38 | $436 | $11 |
| Doxycycline Hyclate | 11 | $368 | $33 |
| Erythromycin | 43 | $349 | $8 |
2022: 9 drugs
| Lumigan | 55 | $14,736 | $268 |
| Simbrinza | 21 | $4,322 | $206 |
| Tobradex St | 15 | $3,757 | $250 |
| Tobramycin-Dexamethasone | 22 | $1,756 | $80 |
| Doxycycline Hyclate | 11 | $976 | $89 |
| Moxifloxacin | 20 | $542 | $27 |
| Latanoprost | 28 | $325 | $12 |
| Erythromycin | 28 | $303 | $11 |
| Neomycin-Polymyxin-Dexameth | 11 | $199 | $18 |
2021: 7 drugs
| Lumigan | 68 | $16,808 | $247 |
| Simbrinza | 21 | $4,026 | $192 |
| Tobramycin-Dexamethasone | 37 | $2,668 | $72 |
| Doxycycline Hyclate | 11 | $1,095 | $100 |
| Bacitracin | 12 | $1,075 | $90 |
| Latanoprost | 32 | $813 | $25 |
| Erythromycin | 15 | $168 | $11 |
2020: 4 drugs
| Lumigan | 65 | $16,435 | $253 |
| Simbrinza | 19 | $3,262 | $172 |
| Tobramycin-Dexamethasone | 40 | $2,831 | $71 |
| Latanoprost | 50 | $1,148 | $23 |
2019: 8 drugs
| Lumigan | 63 | $15,125 | $240 |
| Restasis | 12 | $14,374 | $1,198 |
| Tobramycin-Dexamethasone | 93 | $6,418 | $69 |
| Bacitracin | 22 | $1,998 | $91 |
| Simbrinza | 11 | $1,870 | $170 |
| Latanoprost | 29 | $705 | $24 |
| Timolol Maleate | 11 | $123 | $11 |
| Erythromycin | 11 | $108 | $10 |
2018: 12 drugs
| Restasis | 20 | $18,107 | $905 |
| Lumigan | 63 | $13,868 | $220 |
| Tobramycin-Dexamethasone | 65 | $4,706 | $72 |
| Simbrinza | 25 | $3,939 | $158 |
| Tobradex | 12 | $2,643 | $220 |
| Bacitracin | 12 | $804 | $67 |
| Moxifloxacin | 12 | $662 | $55 |
| Latanoprost | 35 | $633 | $18 |
| Prednisolone Acetate | 14 | $606 | $43 |
| Timolol Maleate | 17 | $122 | $7 |
| Atorvastatin | 11 | $106 | $10 |
| Erythromycin | 11 | $98 | $9 |
2017: 11 drugs
| Lumigan | 87 | $17,687 | $203 |
| Restasis | 28 | $16,901 | $604 |
| Nevanac | 24 | $5,844 | $244 |
| Tobramycin-Dexamethasone | 82 | $5,574 | $68 |
| Simbrinza | 25 | $3,509 | $140 |
| Combigan | 12 | $2,724 | $227 |
| Vigamox | 16 | $2,495 | $156 |
| Xalatan | 13 | $2,314 | $178 |
| Moxifloxacin | 14 | $1,512 | $108 |
| Prednisolone Acetate | 27 | $1,187 | $44 |
| Latanoprost | 26 | $282 | $11 |
2016: 12 drugs
| Lumigan | 88 | $18,622 | $212 |
| Restasis | 24 | $13,179 | $549 |
| Nevanac | 28 | $6,319 | $226 |
| Vigamox | 29 | $4,350 | $150 |
| Tobramycin-Dexamethasone | 59 | $3,442 | $58 |
| Combigan | 11 | $2,269 | $206 |
| Simbrinza | 16 | $2,133 | $133 |
| Xalatan | 14 | $2,111 | $151 |
| Bacitracin | 18 | $1,443 | $80 |
| Prednisolone Acetate | 26 | $930 | $36 |
| Timolol Maleate | 22 | $172 | $8 |
| Latanoprost | 20 | $166 | $8 |
2015: 11 drugs
| Lumigan | 109 | $19,493 | $179 |
| Nevanac | 33 | $7,295 | $221 |
| Vigamox | 33 | $4,442 | $135 |
| Travatan Z | 11 | $4,098 | $373 |
| Combigan | 17 | $3,244 | $191 |
| Tobramycin-Dexamethasone | 38 | $3,185 | $84 |
| Xalatan | 13 | $1,723 | $133 |
| Simbrinza | 13 | $1,541 | $119 |
| Prednisolone Acetate | 20 | $944 | $47 |
| Latanoprost | 33 | $406 | $12 |
| Timolol Maleate | 13 | $99 | $8 |
2014: 12 drugs
| Lumigan | 93 | $13,529 | $145 |
| Doxycycline Hyclate | 14 | $4,678 | $334 |
| Nevanac | 26 | $4,494 | $173 |
| Tobramycin-Dexamethasone | 44 | $4,415 | $100 |
| Combigan | 27 | $3,894 | $144 |
| Travatan Z | 11 | $2,812 | $256 |
| Xalatan | 14 | $1,683 | $120 |
| Vigamox | 14 | $1,592 | $114 |
| Lotemax | 11 | $1,587 | $144 |
| Latanoprost | 28 | $364 | $13 |
| Erythromycin | 13 | $183 | $14 |
| Timolol Maleate | 11 | $80 | $7 |
2013: 10 drugs
| Lumigan | 70 | $10,125 | $145 |
| Tobramycin-Dexamethasone | 44 | $4,034 | $92 |
| Travatan Z | 15 | $3,232 | $215 |
| Combigan | 30 | $2,927 | $98 |
| Acuvail | 12 | $2,205 | $184 |
| Zymaxid | 14 | $1,549 | $111 |
| Xalatan | 13 | $1,437 | $111 |
| Doxycycline Hyclate | 12 | $867 | $72 |
| Erythromycin | 21 | $330 | $16 |
| Latanoprost | 20 | $299 | $15 |
Money from drug and device companies
$21 in 2025
| 2025 | 1 | 1 | None | $21 |
| 2024 | 3 | 3 | None | $83 |
| 2023 | 2 | 3 | None | $81 |
| 2022 | 3 | 21 | None | $276 |
| 2021 | 2 | 20 | None | $223 |
| 2020 | 5 | 23 | $150 | $552 |
| 2019 | 5 | 6 | None | $449 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Botox | $21 | 1 payment
|
See the published payment
| Abbvie | Meals · 2025-08-02 | Botox | $21 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $83
| Gilead Sciences | None | $50 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $20 | 1 payment
|
| Harrow Eye | Vevye | $14 | 1 payment
|
2023: $81
| Eyevance Pharmaceuticals | Tobradex St | $51 | 2 payments
|
| Novartis Pharmaceuticals | Xiidra | $29 | 1 payment
|
2022: $276
| Eyevance Pharmaceuticals | Tobradex St | $189 | 18 payments
|
| Allergan | Vuity | $54 | 2 payments
|
| Johnson & Johnson Vision Care | Acuvue | $34 | 1 payment
|
2021: $223
| Eyevance Pharmaceuticals | Tobradex St | $209 | 19 payments
|
| Allergan | Restasis Multidose | $14 | 1 payment
|
2020: $552
| Eyevance Pharmaceuticals | Flarex | $252 | 19 payments
|
| Galderma Laboratories L.P. | None | $150 | 1 payment
|
| Imperative Care | Imperative Care Zoom | $111 | 1 payment
|
| Carl Zeiss Meditec AG | None Specified | $19 | 1 payment
|
| Allergan | Restasis | $19 | 1 payment
|
2019: $449
| Merz North America | Xeomin | $212 | 1 payment
|
| Alcon Vision | None | $155 | 2 payments
|
| Johnson & Johnson Vision Care | Acuvue | $37 | 1 payment
|
| Akorn | Zioptan | $23 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $22 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 6.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1003817776
- Licence
- CA A76003California A76003: Current · expires 2026-10-31
- Trained
- Wright State University Boonshoft School of Medicine, 1996
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 525 South Drive, Suite 219, Mountain View, CA, 94040
- NPI first listed
- 2005-08-03
- NPI last updated
- 2008-05-29
This is when the NPI record was last certified, not a medical board exam.